Estrogen Regulation of Angiotensin-Converting Enzyme mRNA
- 1 January 1999
- journal article
- other
- Published by Wolters Kluwer Health in Hypertension
- Vol. 33 (1) , 323-328
- https://doi.org/10.1161/01.hyp.33.1.323
Abstract
—Estrogen replacement therapy is cardioprotective in postmenopausal women; however, the precise molecular mechanisms for this modulation are not fully elucidated. We previously showed that chronic estrogen replacement therapy reduced angiotensin-converting enzyme (ACE) activity in tissue extracts and serum with an associated reduction in plasma angiotensin II. A reverse transcriptase–polymerase chain reaction assay was developed to determine whether estrogen treatment regulates tissue ACE mRNA concentration. Total RNA was isolated from kidney cortex, kidney medulla, lung, and aorta of ovariectomized Sprague-Dawley rats after 21 days of chronic 17β-estradiol replacement therapy (5 mg pellet per rat SC) or placebo. A marked decrease in densitometric intensity ratios of amplified ACE cDNA to elongation factor-1α control cDNA was observed in all tissues from placebo-treated rats compared with the estradiol-treated rats (renal cortex: 0.29±0.04 versus 0.14±0.02; renal medulla: 0.37±0.04 versus 0.24±0.03; lung: 4.49±0.37 versus 2.49±0.59; and aorta: 0.41±0.04 versus 0.29±0.02; all P <0.05). A comparable reduction in ACE activity was detected in tissue extracts from kidney cortex, kidney medulla, and lung of hormone-treated animals. Incubation of purified rat lung ACE with 1 or 10 μmol/L 17β-estradiol had no effect on enzyme activity. These results suggest that estrogen treatment regulates tissue ACE activity by reducing ACE mRNA concentrations. Thus, the beneficial cardiovascular effects of estrogen may be mediated in part by downregulation of ACE with a consequent reduction in the circulating levels of the vasoconstrictor angiotensin II, a decrease in the metabolism of the vasodilator bradykinin, and an increase in the production of the vasorelaxant angiotensin-(1–7).Keywords
This publication has 37 references indexed in Scilit:
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Drug Evaluations Cardiovascular & Renal: Biology of angiotensin II receptor inhibition with a focus on losartan: A new drug for the treatment of hypertensionExpert Opinion on Investigational Drugs, 1996
- Increased Expression of Endothelial Constitutive Nitric Oxide Synthase in Rat Aorta during PregnancyBiochemical and Biophysical Research Communications, 1994
- A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: Angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11Life Sciences, 1993
- Renin messenger RNA, detected by polymerase chain reaction, can be switched on in rat atriumJournal Of Hypertension, 1993
- Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats.Hypertension, 1992
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Genomic DNA 5′ to the mouse and human angiotensin-converting enzyme genes contains two distinct regions of conserved sequenceBiochemical and Biophysical Research Communications, 1990
- Isolation of cDNA clones of rabbit angiotensin converting enzyme: Identification of two distinct mRNAs for the pulmonary and the testicular isozymesBiochemical and Biophysical Research Communications, 1988
- The Influence of Normotensive Pregnancy and Pre‐Eclampsia on Angiotensin‐Converting EnzymeActa Obstetricia et Gynecologica Scandinavica, 1983